Palisade Bio Inc. (NASDAQ: PALI)
$4.41
+0.1100 ( +2.56% ) 105.0K
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Market Data
Open
$4.41
Previous close
$4.30
Volume
105.0K
Market cap
$4.14M
Day range
$4.23 - $4.57
52 week range
$3.82 - $36.60
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 22, 2024 |
| ars | Annual reports | 1 | May 22, 2024 |
| def | Proxies and info statements | 6 | May 22, 2024 |
| 3 | Insider transactions | 1 | May 16, 2024 |
| 10-q | Quarterly Reports | 54 | May 13, 2024 |
| 8-k | 8K-related | 17 | May 10, 2024 |
| 4 | Insider transactions | 1 | May 08, 2024 |
| 4 | Insider transactions | 1 | May 08, 2024 |
| 8-k | 8K-related | 21 | May 03, 2024 |
| 8-k | 8K-related | 43 | Apr 10, 2024 |